Workflow alignment, e-prescribing integration, and behavior change strategies are critical to reducing friction across the direct-to-patient ecosystem.
Brok Vandersteen, AssistRx
Advertisement
Brok Vandersteen is a VP of business development at AssistRx.
Articles by Brok Vandersteen, AssistRx
Brok Vandersteen explains how life sciences companies can strategically adopt DTP models for better patient access and commercial success.
Brok Vandersteen, VP of Business Development, AssistRX, explains how policy pressures push life sciences companies toward direct-to-patient model adoption.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The New Era of Pharma Distribution: Balancing Precision and Scale
2
What Germany's Drug Rebate Hike Means for US Pharma
3
Q&A: What Will It Take to Reshore US Drug Manufacturing?
4
Q&A: How Pharma 3PL Is Evolving Beyond the Pallet
5